Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.

Komori, Mika; Lin, Yen Chih; Cortese, Irene; Blake, Andrew; Ohayon, Joan; Cherup, Jamie; Maric, Dragan; Kosa, Peter; Wu, Tianxia; Bielekova, Bibiana

Komori, Mika; Lin, Yen Chih; Cortese, Irene; Blake, Andrew; Ohayon, Joan; Cherup, Jamie; Maric, Dragan; Kosa, Peter; Wu, Tianxia; Bielekova, Bibiana.

Afiliação

Komori M; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland.
Lin YC; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland.
Cortese I; Neuroimmunology Clinic NINDS Bethesda Maryland.
Blake A; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland.
Ohayon J; Neuroimmunology Clinic NINDS Bethesda Maryland.
Cherup J; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland.
Maric D; Flow Cytometry Core Facility NINDS Bethesda Maryland.
Kosa P; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland.
Wu T; Clinical Neuroscience Program NINDS Bethesda Maryland.
Bielekova B; Neuroimmunological Diseases Unit National Institute of Neurological Disorders and Stroke (NINDS) Bethesda Maryland; NIH Center for Human Immunology (CHI)the National Institutes of Health (NIH) Bethesda Maryland.

Ann Clin Transl Neurol ; 3(3): 166-79, 2016 03.

Article em En | MEDLINE | ID: mdl-27042677

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google